Nevro Reports Second Quarter 2016 Financial Results

Go back to Nevro Reports Second Quarter 2016 Financial Results

Piper Jaffray Remains Bullish on Nevro (NVRO) Following 2Q Beat and Raise

August 9, 2016 8:23 AM EDT

Piper Jaffray reiterated an Overweight rating on Nevro Corp (NYSE: NVRO), and raised the price target to $112.00 (from $98.00), following the company's 2Q earnings report. 2Q16 revenues were $55.4 million, primarily due to the ongoing launch of HF10 therapy in the United States. Full-year 2016 revenue guidance was... More

Nevro (NVRO) Tops Q2 EPS by 16c; Guides FY16 Revenue Above Views

August 8, 2016 4:11 PM EDT

Nevro (NYSE: NVRO) reported Q2 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $55.4 million versus the consensus estimate of $45.11 million.

GUIDANCE:

Nevro sees FY2016 revenue of $210-220 million, versus the consensus of $188.7... More